FDA Hiring CBD Testing Contractor
Tue / Aug 18th
The FDA announced it is hiring a third-party contractor to test CBD “and related cannabinoids” for the agency.
The US Food and Drug Administration (FDA) is currently working to understand how cannabis and isolated CBD products can be useful to American citizens. There are robust statistics and stories emerging as the FDA conducts cannabis research. Read more about these details in the following stories, and sign up for our newsletter to be the first to find out when news hits the wire.
Tue / Aug 18th
The FDA announced it is hiring a third-party contractor to test CBD “and related cannabinoids” for the agency.
Mon / Aug 3rd
The FDA has expanded the label of Epidiolex, the first CBD-based medication approved by the federal agency, to treat seizures resulting from tuberous sclerosis complex.
Wed / Jul 22nd
The FDA has opened public comments for new preliminary guidance from the agency for cannabis pharmaceutical research.
Tue / Jun 9th
The FTC has filed a rare lawsuit against CBD company Whole Leaf Organics over unfounded treatment claims made by the company.
Mon / May 18th
Summitt Labs announced last week it was voluntarily recalling Batch#730 Lot#K018 of its Kore Organic Watermelon CBD Oil Tincture.
Tue / Apr 28th
The FDA has issued warnings to two CBD companies over claims that their products could treat opioid addiction and/or replace pharmaceutical drugs.
Tue / Apr 21st
The Hemp Feed Coalition is submitting an application to get hemp approved as chicken feed by the FDA; the process could take 18 months or longer.
Thu / Jan 16th
Lawmakers questioned officials from the DEA, FDA, and National Institutes of Health yesterday about the federal limitations on cannabis research; Rep. Joe Kennedy III (D-MA) accused the government agencies of hiding behind a cannabis “Catch-22.”
Wed / Nov 27th
A new FDA consumer update claims that CBD “has the potential to harm” and suggests that symptoms could range from potential mood swings to even male infertility.
Tue / Nov 26th
Senate Majority Leader Mitch McConnell recently met with FDA Commissioner nominee Dr. Stephen Hahn and discussed the need for a federal CBD regulatory framework.
Tue / Nov 12th
The FDA has approved a human trials study by the Yale School of Medicine and CT Pharma investigating the effectiveness of cannabis-based medicines; it’s the first cannabis study on human subjects to be approved by the FDA.
Tue / Sep 10th
Researchers at Johns Hopkins University announced last week the formation of what is likely the world’s largest research facility dedicated to psilocybin and psychedelic medicinal research.
Fri / Aug 16th
Washington state Ag Department officials recently clarified that hemp-derived CBD is not allowed as a food additive.
Tue / Jul 16th
FDA officials say they will rush the release of federal CBD rules and regulations, potentially by the end of summer or early fall.
Tue / Jun 25th
Three weeks after its first public hearing on cannabidiol, the FDA says it will apply a “rigorous and science-based approach” to devising CBD regulations; however, despite the quickly growing marketplace, the agency has not yet set any official guidelines.
Mon / Jun 10th
Grocery store chain Kroger has begun selling CBD topicals at its stores in 17 states, joining a growing trend of traditional corporate retailers who are embracing CBD products since hemp was federally legalized last year.
Tue / Jun 4th
The FDA’s first-ever CBD hearing took place last Friday. The agency heard from a host of speakers including nutritional supplement experts, private citizens, medical cannabis patients, hemp businesses, and more.
Thu / Apr 11th
The FDA last month warned three U.S. companies who were distributing hemp-derived CBD products that their products violate federal law.
Wed / Apr 3rd
The FDA is planning a public hearing next month to consider the safety, manufacturing, product quality, marketing, labeling, and sale of federally regulated CBD products.
Wed / Mar 6th
FDA Commissioner Dr. Scott Gottlieb, who just announced plans to create federal CBD regulations, now says he will retire next month.
Fri / Mar 1st
FDA Commissioner Dr. Scott Gotliebb is planning a meeting for public comment and testimony in April about creating a regulatory framework for CBD.
Wed / Dec 26th
FDA Commissioner Scott Gottlieb says the agency has started creating a regulatory framework for CBD products, which were legalized via the 2018 Farm Bill.
Tue / Nov 20th
U.S. Food and Drugs Administration (FDA) Commissioner Scott Gottlieb said in a CNBC interview on Friday that a federal cannabis… Read More
Thu / Nov 1st
The first FDA-approved medication containing cannabidiol (CBD) sourced from cannabis plants is now available by prescription in all 50 U.S.… Read More
Website & branding by the Ganjapreneur in-house agency:
Uplifted cannabis industry branding & marketing.